awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34021572-AB807993-B006-4A2B-8F69-A48595C3E2AE
Q34021572-AB807993-B006-4A2B-8F69-A48595C3E2AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34021572-AB807993-B006-4A2B-8F69-A48595C3E2AE
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.
P2860
Q34021572-AB807993-B006-4A2B-8F69-A48595C3E2AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34021572-AB807993-B006-4A2B-8F69-A48595C3E2AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc50294c32435245642cfa5702a92b26da5c83a3
P2860
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.